|
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
|
MJTV New Line Hits on Hot Consumer Markets |
|
Hot Stock to Watch |
Company: Michael James Enterprises, Inc. (OTCQB: MJTV)
|
Last: Price: 0.095 Change (%): + 0.00 (0.00) Volume: 0 |
|
Michael James Enterprises Creates New Line of Neuroceuticals and Begins Development of New Website WHIPPANY, NJ-(Marketwired - Sep 21, 2016) - Michael James Enterprises, Inc. (OTCQB: MJTV) is pleased to report that it will be adding a new line of product offerings as Neuroceuticals to the already existing line of Pharmaceuticals. MJTV also has a new web page up www.mjbiotech.com. The website will be expanded and further developed over the coming weeks. MJTV will begin with two new products under its neuroceutical line. Patents and trademarks will be filed very soon at which time the specific products will be announced. Each product will have a brand ambassador and will be sold via direct response through all mediums and through any distribution channel that makes sense. James Farinella, CEO of Michael James Enterprises, stated, “We expect very big things from these two new neuroceutical therapeutic offerings. We are not the typical biotech company. We will look to have two or three different lines from Neutriceuticals, Neuroceuticals to Pharmaceuticals. Pharmaceuticals take a much longer period of time to bring to market, while the other two lines can be brought to market over the counter almost immediately providing for a revenue generating stable company environment.” Continue Reading
|
|
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|